Novation awards cardiovascular product contracts
Novation, a healthcare contracting services provider of the healthcare alliances VHA and the University HealthSystem Consortium, has awarded 33 multi-source agreements for cardiovascular products to its cardiovascular portfolio. The Irving, Texas-based Novation said it could provide up to $267 million in savings for alliance member hospitals.
The 33 contracts were awarded to 13 companies, and the agreements take effect Oct. 1 through Sept. 30, 2010.
The companies, which received the contracts are: Abbott Vascular; Bard EP and Bard Peripheral; Boston Scientific; Cardiva Medical; ev3; Marine Polymer; Merit Medical; Medtronic; Terumo; and TZ Medical.
The product categories include electrophysiology; percutaneous coronary intervention; coronary diagnostic; vascular closure devices; peripheral interventional; peripheral diagnostic; thrombus management; neuro interventional and cardiac rhythm management.
The 33 contracts were awarded to 13 companies, and the agreements take effect Oct. 1 through Sept. 30, 2010.
The companies, which received the contracts are: Abbott Vascular; Bard EP and Bard Peripheral; Boston Scientific; Cardiva Medical; ev3; Marine Polymer; Merit Medical; Medtronic; Terumo; and TZ Medical.
The product categories include electrophysiology; percutaneous coronary intervention; coronary diagnostic; vascular closure devices; peripheral interventional; peripheral diagnostic; thrombus management; neuro interventional and cardiac rhythm management.